Lovenox (enoxaparin sodium) Injection
Company: Rhone Poulenc Rorer
Approval Status: Approved January 1999
Treatment for: Hematology
Areas: Hematology
Possible similar drugs: Lovenox; Lovenox
General Information
Other Useful Resources
Lovenox has been approved for the following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
